Xeris Pharmaceuticals Inc. (XERS) Tops Q1 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: XERS) | Delayed: 10.75 +0.11 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.64 | 52 Week High | $ | |||
| Open | $10.80 | 52 Week Low | $ | |||
| Day High | $10.95 | P/E | N/A | |||
| Day Low | $10.71 | EPS | $ | |||
| Volume | 1,745,556 | |||||
